3 patient groups sue US over drug copay assistance rule
(By Mackenzie Bean for Becker’s Hospital Review) Three patient advocacy groups are suing the U.S. government to challenge the legality
Read More
Part D/Prescription Drugs
FDA expected to authorize new omicron-specific COVID boosters this week
(By Rob Stein for NPR) The U.S. Food and Drug Administration this week is expected to authorize the first updated
Read MoreKeep an eye out for your Annual Notice of Change
Medicare recipients should receive their Annual Notice of Change (ANOC) by the end of September. This notice is generated by
Read MoreMedicare Advantage Is Close to Becoming the Predominant Way That Medicare Beneficiaries Get Their Health Coverage and Care
(By Kaiser Family Foundation Published: Aug 25, 2022) As Medicare Advantage continues to grow, a gradual but significant reshaping of
Read MoreSpending on Medicare Advantage Quality Bonus Program Payment Reached $10 Billion in 2022
(By Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for Kaiser Family Foundation Published: Aug 25, 2022) The
Read MoreMedicare Advantage in 2022: Premiums, Out-of-Pocket Limits, Cost Sharing, Supplemental Benefits, Prior Authorization, and Star Ratings
(By Meredith Freed , Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for Kaiser Family Foundation Published: Aug 25, 2022)
Read MoreThe biggest winners of the Inflation Reduction Act
For the first time in history, Medicare has the power to negotiate drug prices. Granted, in the beginning, the number
Read MoreHow Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?
(By Juliette Cubanski, Tricia Neuman, Meredith Freed, and Anthony Damico for Kaiser Family Foundation Published: Aug 18, 2022) On August
Read MoreKey Facts About Medicare Part D Enrollment and Costs in 2022
(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation Published: Aug 17, 2022) The Medicare Part D program provides
Read MoreStates continue regulatory onslaught against PBMs
(By Jakob Emerson for Becker’s Hospital Review) State legislative efforts to regulate or increase transparency policies around pharmacy benefit managers
Read More